Scholar Rock Holding Corp. (SRRK)
58.85
+0.65
(+1.12%)
USD |
NASDAQ |
Aug 25, 13:04
Scholar Rock Price to Book Value : 28.20 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 27.89 |
| August 21, 2026 | 27.07 |
| August 20, 2026 | 26.47 |
| August 19, 2026 | 27.08 |
| August 18, 2026 | 26.22 |
| August 17, 2026 | 24.94 |
| August 14, 2026 | 25.16 |
| August 13, 2026 | 25.42 |
| August 12, 2026 | 25.79 |
| August 11, 2026 | 24.95 |
| August 10, 2026 | 24.86 |
| August 07, 2026 | 25.36 |
| August 06, 2026 | 25.22 |
| August 05, 2026 | 22.94 |
| August 04, 2026 | 22.90 |
| August 03, 2026 | 21.97 |
| July 31, 2026 | 22.66 |
| July 30, 2026 | 23.47 |
| July 29, 2026 | 23.51 |
| July 28, 2026 | 23.66 |
| July 27, 2026 | 23.44 |
| July 24, 2026 | 22.84 |
| July 23, 2026 | 23.71 |
| July 22, 2026 | 23.14 |
| July 21, 2026 | 24.38 |
| Date | Value |
|---|---|
| July 20, 2026 | 24.27 |
| July 17, 2026 | 25.33 |
| July 16, 2026 | 24.79 |
| July 15, 2026 | 25.89 |
| July 14, 2026 | 25.77 |
| July 13, 2026 | 26.21 |
| July 10, 2026 | 27.17 |
| July 09, 2026 | 27.76 |
| July 08, 2026 | 26.85 |
| July 07, 2026 | 27.10 |
| July 06, 2026 | 26.53 |
| July 02, 2026 | 26.30 |
| July 01, 2026 | 25.32 |
| June 30, 2026 | 26.35 |
| June 29, 2026 | 23.72 |
| June 26, 2026 | 23.63 |
| June 25, 2026 | 23.21 |
| June 24, 2026 | 22.58 |
| June 23, 2026 | 22.12 |
| June 22, 2026 | 21.23 |
| June 18, 2026 | 20.42 |
| June 17, 2026 | 20.26 |
| June 16, 2026 | 19.66 |
| June 15, 2026 | 19.82 |
| June 12, 2026 | 19.06 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.52 |
| Anika Therapeutics, Inc. | 2.106 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.838 |
Price to Book Value Related Metrics
| PEG Ratio | -1.184 |
| Price | 58.85 |
| Earnings Yield | -5.87% |
| Market Cap | 7.156B |
| PEGY Ratio | -1.184 |